» Articles » PMID: 89292

Evidence of Whooping-cough-vaccine Efficacy from the 1978 Whooping-cough Epidemic in Hertfordshire

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1979 Jul 28
PMID 89292
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The question of the efficacy of whooping-cough immunisation was central to the controversy that started in 1974. Definitive answers were not possible at the time because of the very low levels of whooping-cough in the preceding years and the absence of up-to-date information. The widespread abandonment of whooping-cough immunisation and the subsequent epidemic of whooping-cough have provided a natural epidemiological experiment. Figures from Hertfordshire in 1978 show that for children aged 4 years and under whooping-cough immunisation conferred 92% protection.

Citing Articles

Characterization of co-purified acellular pertussis vaccines.

Xu Y, Tan Y, Asokanathan C, Zhang S, Xing D, Wang J Hum Vaccin Immunother. 2015; 11(2):421-7.

PMID: 25610957 PMC: 4514368. DOI: 10.4161/21645515.2014.988549.


Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

Ross P, Sutton C, Higgins S, Allen A, Walsh K, Misiak A PLoS Pathog. 2013; 9(4):e1003264.

PMID: 23592988 PMC: 3617212. DOI: 10.1371/journal.ppat.1003264.


Support for preventive public health programs.

Butler-Jones D Can Fam Physician. 2011; 33:1051-2.

PMID: 21263917 PMC: 2218457.


A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

Mills K, Ryan M, Ryan E, Mahon B Infect Immun. 1998; 66(2):594-602.

PMID: 9453614 PMC: 107945. DOI: 10.1128/IAI.66.2.594-602.1998.


Toward safer and more efficient pertussis vaccines.

Wegmann A, GLUCK R Eur J Pediatr. 1996; 155(2):71-3.

PMID: 8775215 DOI: 10.1007/BF02075752.